FUNCTIONAL AREAS – Page 45

Periodic report inconsistencies during audit response – regulatory enforcement risk and mitigation

The first critical step in addressing periodic report inconsistencies is recognizing the signals that indicate a problem. Symptoms may arise from various stages of the pharmaceutical manufacturing and quality control…

Material specification drift during development – inspection evidence expectations

Identifying the symptoms of material specification drift is crucial for timely intervention. Common signals include:Click to read the full article.

Periodic report inconsistencies during post-marketing surveillance – inspection questioning scenarios

The initial identification of anomalies in periodic reports often comes from various signals that staff may encounter during the monitoring process or by scrutinizing the reports themselves. Operators may notice…

Material specification drift during market launch – how to prevent recall triggers

Recognizing the symptoms or signals of material specification drift is crucial for prompt detection and resolution. Some common indicators on the manufacturing floor or in quality control laboratories include:Click to…

AE reporting non-compliance during signal review – how to strengthen benefit–risk documentation

Identifying signals of AE reporting non-compliance during the signal review stage is crucial. Symptoms may manifest in various forms, including:Click to read the full article.

Artwork change error during scale-up – regulatory risk analysis and mitigation

Detecting an artwork change error early in the scale-up process is vital for compliance and product integrity. Key signals may include:Click to read the full article.

Literature surveillance failure during inspection – regulatory enforcement risk and mitigation

Identifying symptoms or signals of a literature surveillance failure is critical for timely and effective intervention. Symptoms may arise from various aspects of your pharmacovigilance activities and can include:Click to…

Artwork change error during development – documentation gaps regulators question

Typically, artwork change errors manifest in various ways within manufacturing operations. Important signals to look for include:Click to read the full article.

Literature surveillance failure during benefit–risk assessment – inspection questioning scenarios

Identifying symptoms of literature surveillance failures is the first step in initiating an investigation. Common signs include:Click to read the full article.

Material specification drift during supplier change – inspection evidence expectations

Identifying symptoms and signals associated with material specification drift is critical for prompt action. Common signals can include:Click to read the full article.

Case processing backlog during signal review – inspection questioning scenarios

Understanding the symptoms of a case processing backlog is the first step toward resolution. Symptoms may manifest as:Click to read the full article.

Container closure integrity risk during scale-up – inspection evidence expectations

Understanding the symptoms indicative of container closure integrity risk during scale-up is crucial. Early detection can save a manufacturing batch from potential rejection during FDA or EMA inspections and help…